Harrow Net Debt from 2010 to 2024

HROWL Stock

USD 25.39 0.03 0.12%

Harrow Health Net Debt yearly trend continues to be quite stable with very little volatility. Net Debt may rise above about 122.2 M this year. Net Debt is the total debt of Harrow Health 8625 minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2006-09-30

Previous Quarter

121.4 M

Current Value

123.5 M

Quarterly Volatility

40 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 70.3 M or Selling And Marketing Expenses of 5.2 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.93. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.

Check out the analysis of Harrow Health Correlation against competitors.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

Latest Harrow Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of Harrow Health 8625 over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Harrow Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Harrow Net Debt Regression Statistics

	Arithmetic Mean	21,025,706
	Geometric Mean	8,737,946
	Coefficient Of Variation	199.03
	Mean Deviation	28,182,231
	Median	7,904,000
	Standard Deviation	41,847,337
	Sample Variance	1751.2T
	Range	137.8M
	R-Value	0.75
	Mean Square Error	838.3T
	R-Squared	0.56
	Significance	0
	Slope	6,974,107
	Total Sum of Squares	24516.8T

Harrow Net Debt History

	2024	122.2 M
	2023	116.4 M
	2022	7.9 M
	2021	35.8 M
	2020	19.4 M
	2019	16.2 M
	2018	8.6 M

Other Fundumenentals of Harrow Health 8625

Net Debt To E B I T D A

Harrow Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Current Deferred Revenue	Short Term Debt	Net Receivables	Good Will	Short Term Investments	Intangible Assets	Long Term Debt	Capital Surpluse	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Long Term Investments
Total Assets		0.94	0.95	-0.82	1.0	0.97	0.6	0.95	0.27	-0.11	0.96	-0.3	0.24	0.96	0.95	0.84	-0.49	-0.79	0.84	0.79
Total Stockholder Equity	0.94		0.89	-0.75	0.91	0.9	0.58	0.88	0.25	0.04	0.92	-0.34	0.44	0.91	0.81	0.78	-0.25	-0.61	0.69	0.62
Net Debt	0.95	0.89		-0.76	0.94	0.85	0.54	0.84	0.22	-0.05	0.97	-0.22	0.26	0.96	0.83	0.72	-0.39	-0.7	0.71	0.67
Retained Earnings	-0.82	-0.75	-0.76		-0.82	-0.84	-0.84	-0.85	-0.3	-0.1	-0.72	-0.07	-0.38	-0.69	-0.79	-0.8	0.43	0.72	-0.74	-0.72
Total Liab	1.0	0.91	0.94	-0.82		0.97	0.6	0.95	0.28	-0.15	0.96	-0.28	0.19	0.95	0.96	0.84	-0.55	-0.83	0.87	0.82
Total Current Assets	0.97	0.9	0.85	-0.84	0.97		0.67	0.97	0.32	-0.09	0.87	-0.35	0.29	0.86	0.97	0.9	-0.52	-0.85	0.9	0.85
Common Stock	0.6	0.58	0.54	-0.84	0.6	0.67		0.66	0.4	0.33	0.46	-0.03	0.58	0.42	0.6	0.81	-0.27	-0.59	0.65	0.66
Accounts Payable	0.95	0.88	0.84	-0.85	0.95	0.97	0.66		0.43	-0.08	0.87	-0.2	0.26	0.86	0.93	0.88	-0.49	-0.76	0.86	0.78
Current Deferred Revenue	0.27	0.25	0.22	-0.3	0.28	0.32	0.4	0.43		0.52	0.21	0.28	0.32	0.19	0.25	0.37	-0.09	-0.11	0.25	0.17
Short Term Debt	-0.11	0.04	-0.05	-0.1	-0.15	-0.09	0.33	-0.08	0.52		-0.12	0.22	0.62	-0.18	-0.24	-0.02	0.49	0.28	-0.26	-0.27
Net Receivables	0.96	0.92	0.97	-0.72	0.96	0.87	0.46	0.87	0.21	-0.12		-0.25	0.15	1.0	0.85	0.72	-0.43	-0.67	0.73	0.67
Good Will	-0.3	-0.34	-0.22	-0.07	-0.28	-0.35	-0.03	-0.2	0.28	0.22	-0.25		-0.13	-0.27	-0.35	-0.3	0.0	0.37	-0.35	-0.36
Short Term Investments	0.24	0.44	0.26	-0.38	0.19	0.29	0.58	0.26	0.32	0.62	0.15	-0.13		0.1	0.1	0.35	0.43	-0.07	0.05	0.05
Intangible Assets	0.96	0.91	0.96	-0.69	0.95	0.86	0.42	0.86	0.19	-0.18	1.0	-0.27	0.1		0.86	0.71	-0.46	-0.67	0.73	0.67
Long Term Debt	0.95	0.81	0.83	-0.79	0.96	0.97	0.6	0.93	0.25	-0.24	0.85	-0.35	0.1	0.86		0.86	-0.67	-0.92	0.95	0.92
Capital Surpluse	0.84	0.78	0.72	-0.8	0.84	0.9	0.81	0.88	0.37	-0.02	0.72	-0.3	0.35	0.71	0.86		-0.51	-0.76	0.92	0.87
Property Plant Equipment	-0.49	-0.25	-0.39	0.43	-0.55	-0.52	-0.27	-0.49	-0.09	0.49	-0.43	0.0	0.43	-0.46	-0.67	-0.51		0.74	-0.74	-0.77
Net Tangible Assets	-0.79	-0.61	-0.7	0.72	-0.83	-0.85	-0.59	-0.76	-0.11	0.28	-0.67	0.37	-0.07	-0.67	-0.92	-0.76	0.74		-0.92	-0.96
Long Term Debt Total	0.84	0.69	0.71	-0.74	0.87	0.9	0.65	0.86	0.25	-0.26	0.73	-0.35	0.05	0.73	0.95	0.92	-0.74	-0.92		0.98
Long Term Investments	0.79	0.62	0.67	-0.72	0.82	0.85	0.66	0.78	0.17	-0.27	0.67	-0.36	0.05	0.67	0.92	0.87	-0.77	-0.96	0.98

Click cells to compare fundamentals

About Harrow Health Financial Statements

Harrow Health investors utilize fundamental indicators, such as Net Debt, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	116.4 M	122.2 M
Net Debt To EBITDA	11.97	12.57

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:

How To Invest In Harrow

Details

Is Harrow Stock a good investment?

Details

What is Harrow Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Harrow Health Correlation against competitors.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Return On Equity

0.4484

The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Net Debt from 2010 to 2024

Latest Harrow Health's Net Debt Growth Pattern

Harrow Net Debt Regression Statistics

Harrow Net Debt History

Other Fundumenentals of Harrow Health 8625

Harrow Health Net Debt component correlations

About Harrow Health Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY